Heller RS

Language: Spanish
References: 8
Page: 548-549
PDF size: 69.17 Kb.

Text Extraction

No abstract

REFERENCES

1. Hartman C, Berkowutz D, Shouval D, et al. Lamivudine treatment for chronic hepatitis B infection in children unresponsive to interferon. Pediatr Infect Dis J 2003; 22: 234-9.

2. Leung WAJ, Lai Cl, Chang TTl, et al. Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy. Hepatology 2001; 33: 1527-32.

3. Koçak N, Saltik IN, Özen H, Yüce A, Gürakan F. Lamivudine treatment for children with interferon refractory chronic hepatitis B. Hepatology 2000; 31: 545-6.

4. Jonas MM, Kelley DA, Mizerski J, et al. Clinical trial of lamivudine in children with chronic hepatitis B. N Engl J Med 2002; 346: 1706-13.

5. Liberek A, Szaflarska-Popawska A, Korzon M, et al. Lamivudine therapy for children with chronic hepatitis B. World J Gastroenterol 2006; 12: 2412-6.

6. Sokal EM, Kelly DA, Mizerski J, et al. Long-term lamivudine therapy for children with HBeAg-positive chronic hepatitis B. Hepatology 2006; 43: 225-32.

7. Sokucu S, Gokce S, Suoglu OD, Emiroglu H, Ceikbas U. Comparison of interferon monotherapy with interferon-lamivudine combination treatment in children with chronic hepatitis B. Indian J Gastroenter 2006; 25: 136-9.

8. D’Antiga L, Marion AW, Atkins M, et al. Combined lamivudine/interferon-µ treatment in “immunotolerant“ children perinatally infected with hepatitis B: a pilot study. J Pediatr 2006; 148: 228-3.